Specificity of the immune response to a modified group B meningococcal polysaccharide conjugate vaccine

Clinical and Vaccine Immunology

Volumn 14, Issue 1, 2007, Pages 106-109

  Moore, Samuel ^a   Farley, Esmé K ^a   Fusco, Peter C ^a   Michon, Francis ^a  

^a BioVeris Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; BACTERIAL ANTIGEN; BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; VACCINE;

ANTIGEN SPECIFICITY; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOGENICITY; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; SERUM BACTERICIDAL ACTIVITY; VACCINE PRODUCTION; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CLASSIFICATION; IMMUNOLOGY;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; MICE; NEISSERIA MENINGITIDIS; POLYSACCHARIDES, BACTERIAL; VACCINES, CONJUGATE;

EID: 34247859388     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00216-06     Document Type: Article

References (26)

1. Andersen, J., L. Berthelsen, and I. Lind. 1997. Measurement of antibodies against meningococcal capsular polysaccharides B and C in enzyme-linked immunosorbent assays: towards an improved surveillance of meningococcal disease. Clin. Diagn. Lab. Immunol. 4:345-351.
2. Ashton, F. E., J. A. Ryan, F. Michon, and H. J. Jennings. 1989. Protective efficacy of mouse serum to the N-propionyl derivative of meningococcal group B polysaccharide. Microb. Pathog. 6:455-458.
3. Coquillat, D., J. Bruge, B. Danve, M. Latour, C. Hurpin, D. Schulz, P. Durbec, and G. Rougon. 2001. Activity and cross-reactivity of antibodies induced in mice by immunization with a group B meningococcal conjugate. Infect. Immun. 69:7130-7139.
4. Finne, J., M. Leinonen, and P. H. Mäkelä. 1983. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet ii:355-357.
5. Fusco, P. C., M. S. Blake, and F. Michon. 1998. Meningococcal vaccine development: a novel approach. Expert Opin. Investig. Drugs 7:245-252.
6. Fusco, P. C., F. Michon, J. Y. Tai, and M. S. Blake. 1997. Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primates. J. Infect. Dis. 175:364-372.
7. Granoff, D. M., A. Bartoloni, S. Ricci, E. Gallo, D. Rosa, N. Ravenscoft, V. Guarnieri, R. C. Seid, A. Shan, W. R. Usinger, S. Tan, Y. E. McHugh, and G. R. Moe. 1998. Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid. J. Immunol. 160:5028-5036.
8. Jafari, H. S., B. A. Perkins, and J. D. Wenger. 1997. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 46:1-51.
9. Jennings, H. J., A. Gamian, and F. E. Ashton. 1987. N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis. J. Exp. Med. 165:1207-1211.
10. Jennings, H. J., A. Gamian, F. Michon, and F. E. Ashton. 1989. Unique intermolecular bactericidal epitope involving the homosialopolysaccharide capsule on the cell surface of group B Neisseria meningitidis and Escherichia coli K1. J. Immunol. 142:3585-3591.
11. Jennings, H. J., and C. Lugowski. 1981. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. J. Immunol. 127:1011-1018.
12. Jennings, H. J., R. Roy, and A. Gamian. 1986. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine. J. Immunol. 137:1708-1713.
13. Jennings, H. J., R. Roy, and F. Michon. 1985. Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis. J. Immunol. 134:2651-2657.
14. Jennings, H. J. 1997. N-Propionylated group B meningococcal polysaccharide glycoconjugate vaccine against group B meningococcal meningitis. Int. J. Infect. Dis. 1:158-164.
15. Leinonen, M., and C. E. Frasch. 1982. Class-specific antibody response to group B Neisseria meningitidis capsular polysaccharide: use of polylysine precoating in an enzyme-linked immunosorbent assay. Infect. Immun. 38:1203-1207.
16. Mandrell, R. E., and W. D. Zollinger. 1982. Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants. J. Immunol. 129:2172-2178.
17. Michon, F., C. H. Huang, E. K. Farley, L. Hronowski, J. Di, and P. C. Fusco. 2000. Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope. Dev. Biol. (Basel) 103:151-160.
18. Michon, F., C. Uitz, A. Sarkar, A. J. D'Ambra, M. Laude-Sharpe, S. Moore, and P. C. Fusco. 2006. Group B streptococcal type II and III conjugate vaccines: physicochemical properties that influence immunogenicity. Clin. Vaccine Immunol. 13:936-943.
19. Moe, G. R., A. Dave, and D. M. Granoff. 2005. Epitopes recognized by a nonautoreactive murine anti-N-propionyl meningococcal group B polysaccharide monoclonal antibody. Infect. Immun. 73:2123-2128.
20. Moe, G. R., A. Dave, and D. M. Granoff. 2006. Molecular analysis of anti-N-propionyl Neisseria meningitidis group B polysaccharide monoclonal antibodies. Mol. Immunol. 43:1424-1431.
21. Mühlenhoff, M., M. Eckhardt, and R. Gerardy-Schahn. 1998. Polysialic acid: three-dimensional structure, biosynthesis and function. Curr. Opin. Struct. Biol. 8:558-564.
22. Pon, R. A., M. Lussier, Q. L. Yang, and H. J. Jennings. 1997. N-propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis. J. Exp. Med. 185:1929-1938.
23. Ramsay, M., E. Kaczmarski, M. Rush, R. Mallard, P. Farrington, and J. White. 1997. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun. Dis. Rep. CDR Rev. 7:R49-R54.
24. Rosenstein, N. E., B. A. Perkins, D. S. Stephens, T. Popovic, and J. M. Hughes. 2001. Meningococcal disease. N. Engl. J. Med. 344:1378-1388.
25. Wyle, F. A., M. S. Artenstein, B. L. Brandt, E. C. Tramont, D. L. Kasper, P. L. Altieri, S. L. Berman, and J. P. Lowenthal. 1972. Immunologic response of man to group B meningococcal polysaccharide vaccines. J. Infect. Dis. 126:514-521.
26. Zollinger, W. D., R. E. Mandrell, J. M. Griffiss, P. Altieri, and S. Berman. 1979. Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. J. Clin. Investig. 63:836-848.